Drugs / Individualized neoantigen peptides vaccine
Individualized neoantigen peptides vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04397926 | May 2020 → May 2022 | non-small cell lung carcinoma | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Individualized neoantigen peptides vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04397926 ↗ |
| Modality | Vaccine | “Neoantigen vaccine” NCT04397926 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT04397926 ↗ |